"Fondé en 1968, l'Hôpital-Clinique Claude Bernard est reconnu parmi les établissements majeurs de la région. Intégré au groupe ELSAN depuis 2017, il regroupe 120 praticiens, une équipe de 680 personnes. Avec 310 lits et places, 12 salles d’opération, 5 salles d’accouchement, il dispose d'un service d’urgence ouvert 7 jours / 7, un centre SOS main et une maternité. Plus de 52 000 patients ont été pris en charge en 2020. Sa collaboration avec des activités diagnostiques et supports lui permet de proposer sur un site unique, un panel de spécialités complémentaires."

During the past decade, Hôpital Clinique Claude Bernard conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Clinique Claude Bernard" #1 sponsor was "UNICANCER" with 5 trials, followed by "GERCOR - Multidisciplinary Oncology Cooperative Group" with 3 trials sponsored, "Elsan" with 2 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 2 trials sponsored and "Ferring Pharmaceuticals" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Clinique Claude Bernard" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Mario Negri Institute for Pharmacological Research" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Clinique Claude Bernard" are "Breast Cancer" (3 trials), "Prostate Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Colorectal Cancer" (2 trials) and "ALK Gene Mutation" (1 trials). Many other conditions were trialed in "Hôpital Clinique Claude Bernard" in a lesser frequency.

Most popular intervention types in "Hôpital Clinique Claude Bernard" are "Drug" (11 trials), "Procedure" (5 trials), "Radiation" (5 trials), "Other" (3 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (4 trials), "fluorouracil" (3 trials), "cisplatin" (2 trials), "conventional surgery" (2 trials) and "Aromatase Inhibitors" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Clinique Claude Bernard" are 13 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpital Clinique Claude Bernard". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Hôpital Clinique Claude Bernard, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Clinique Claude Bernard, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Hôpital Clinique Claude Bernard has several departments that took part in Clinical trials: "Hopital Clinique Claude Bernard; Oncologie Medicale" - 5 trials